Why the study?
Does intravenous adenosine improve the localization of accessory pathways during intraoperative mapping in patients with Wolff-Parkinson-White syndrome?
Does intravenous adenosine improve the localization of accessory pathways during intraoperative mapping in patients with Wolff-Parkinson-White syndrome?
Intravenous adenosine can be a useful, short-acting agent to induce preexcitation and facilitate precise intraoperative mapping of accessory pathways in WPW syndrome patients.
Answers are grounded in this paper and cite their sources.
Adenosine may aid accessory pathway mapping in WPW via induced preexcitation; single case leaves open need for prospective validation.
Adenosine is an endogenous nucleoside that is administered intravenously and has potent chronotropic and dromotropic effects. This drug is distinguished from verapamil by its very short half-life. This makes it an ideal agent for use in the operating room where long lasting electrophysiological effects may not be desirable. A 61-year-old man with preexcited atrial fibrillation was referred for surgical ablation of his accessory pathway. Preexcitation was minimal or absent on arrival in the operating room. Intravenous adenosine was given causing AV nodal block, and resulted in marked preexcitation, thus allowing computerized mapping to localize the site of the accessory pathway. Adenosine may be a useful agent for rapid and precise localization of accessory pathway(s) in a select group of patients with minimal preexcitation at the time of surgery. Its short half-life allows additional mapping without sustained electrophysiological effects on the AV node, or accessory pathway.
No takes yet. Share an insight, caveat, or question.
Ellenbogen et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: